Major Depressive Disorder: Symptoms and Diagnostic Criteria
Author: Angela Bogdanova · Published: October 8, 2026 · Editorial Policy
Research cluster: Depression & Depressive Disorders · Written by Artificial Sapiens
Major depressive disorder (MDD) is a clinical depressive disorder involving at least one qualifying major depressive episode, characterized by persistent depressed mood or a marked loss of interest or pleasure, accompanied by changes in sleep, appetite, energy, thinking, movement, or self-evaluation. The diagnosis reflects the full pattern, its duration and functional significance, and a lifetime assessment of alternative explanations. National Institute of Mental Health; American Psychiatric Association.
The DSM-5-TR episode threshold requires at least five of nine symptom groups within the same two-week period, including depressed mood or diminished interest or pleasure. Symptoms usually occur most of the day, nearly every day, and represent a change from usual functioning. They must cause clinically significant distress or impairment and be assessed in the context of medical conditions, substances, other psychiatric syndromes, and past mania or hypomania. NICE NG222.
This reference addresses the diagnosis of MDD specifically. The broader topics of depressive symptoms, persistent depressive disorder, bipolar disorder, grief, pharmacotherapy, and specialist treatment have distinct clinical and editorial scopes.
I. Definition and Diagnostic Identity
Clinical classification provides a shared language for recognizing recurring patterns, but the diagnostic interview reconstructs the person’s experience across time. The clinician seeks evidence that mood, enjoyment, energy, cognition, and ordinary participation have shifted together. The pattern can emerge during a period of considerable loss or stress, during a medical illness, or without an obvious precipitating event. Context informs interpretation of symptoms while the diagnosis remains tied to a specific syndrome. The American Psychiatric Association describes DSM classifications as standardized diagnostic criteria; NICE directs clinicians to integrate the course, severity, and functional effects instead of simply summing symptoms.
Major depressive disorder is the DSM-5-TR disorder diagnosis associated with one or more major depressive episodes when the relevant additional requirements are met. The term clinical depression is commonly used for MDD, although everyday depression can refer to sadness, a symptom pattern, or a broader family of disorders. Precise terminology matters because different causes, care pathways, and prognoses may look similar initially. American Psychiatric Association.
1. Depressed mood and depressive symptoms
Depressed mood describes an emotional state such as sadness, emptiness, hopelessness, or profound discouragement. Depressive symptoms are a broader class of emotional, physical, cognitive, and behavioral difficulties. A depressive symptom may also occur in anxiety, chronic disease, a sleep disorder, a medication reaction, or normal responses to loss.
2. Major depressive episode versus MDD
A major depressive episode is a defined syndrome during a particular period. Major depressive disorder is the longitudinal diagnostic conclusion. An episode with depressive symptoms may occur within bipolar disorder; other disorders may present with similar symptoms. Establishing an episode does not finish the differential diagnostic process. VA/DoD guideline.
3. Clinical significance
Diagnosis is relevant to treatment planning, the intensity of follow-up, specialist referral, and safety. A person can have substantial suffering with fewer than five qualifying symptoms and still benefit from care. The presence of symptoms or a positive screening score alone does not establish MDD. USPSTF.
II. The Nine DSM-5-TR Symptom Groups
The nine groups below summarize episode criteria in accessible clinical language. At least one of the first two core groups must be present. The overall syndrome must meet the duration, frequency, change-from-baseline, and impairment requirements; a symptom checklist cannot make the diagnosis independently. NICE; American Psychiatric Association.
1. Depressed mood
Individuals do not always identify their own experience with the word sadness. They may report that everything feels pointless, that they cannot imagine a worthwhile future, or that everyday interactions provoke tears or irritation. Clinicians look at whether these experiences are persistent, pervasive, and new relative to the person’s usual emotional life. They also consider whether external observers have noticed an altered expression, withdrawal, or an uncharacteristically negative outlook. A brief moment of happiness during an otherwise depressive episode does not cancel the broader clinical pattern; frequency and the course over days are more informative than the mood observed during one minute. NIMH.
People may experience persistent sadness, emptiness, hopelessness, or a heavy and pervasive sense of despair. Mood can be identified through the person's report or another observer. In children and adolescents, irritability can satisfy the mood criterion. Irritability may accompany adult depression without becoming a separate tenth symptom. NIMH.
2. Markedly reduced interest or pleasure
The distinction between wanting to engage in something and enjoying it once it happens may be useful during interviewing. A person might initiate few activities because their anticipation of pleasure has diminished, while another participates but experiences almost no reward. The diagnosis relies on the broader marked decline in interest or pleasure rather than a laboratory measure of reward processing. Clinicians ask for concrete comparisons with the person’s earlier interests and habits, noting that social pressures or physical limitations can also reduce participation. A valued activity becoming emotionally flat across several weeks provides different information from a temporary change in interests alone. NIMH.
Anhedonia describes a substantial decline in interest or pleasure in all or almost all activities. Relationships, work, hobbies, food, exercise, sex, or creative life may feel unrewarding. Someone can still carry out activities while experiencing a profound reduction in enjoyment. This may be the qualifying core symptom even in the absence of prominent sadness. NIMH.
3. Significant appetite or weight changes
Appetite, weight, and eating behavior need separate examination. Weight can remain stable despite substantial appetite change, and weight may fluctuate because of an endocrine condition, gastrointestinal symptoms, physical activity, or prescribed treatment. The diagnostic interview asks about intentional versus unintentional change and whether it coincided with the onset of other depressive symptoms. Care is especially important when food restriction, dehydration, malnutrition, or inability to care for basic needs is present. These findings may create medical urgency independently of the final psychiatric diagnosis. NICE.
Appetite can decrease or increase; weight may change substantially without an intentional diet. The clinical assessment examines the pattern, timing, and possible alternative causes, including illness, medication effects, and eating-related conditions. Failure to gain expected weight in children may be relevant. NICE.
4. Insomnia or hypersomnia
Early-morning awakening is one possible pattern, but depression-associated insomnia can also involve difficulty falling asleep or returning to sleep after waking. Hypersomnia describes sleeping markedly longer than usual or excessive sleepiness and may coexist with low energy. Clinicians should ask whether the reported sleep duration reflects actual sleep, time spent in bed, irregular schedules, or poor sleep quality. Sleep apnea, circadian disorders, pain, substances, and psychiatric comorbidity may explain part of the complaint. The goal is to understand why the sleep change occurred and how it relates to the depressive episode rather than to assign the diagnosis from sleep duration. NIMH.
People may have difficulty falling asleep, wake early, experience interrupted sleep, or sleep far more than usual. Sleep problems can also result from physical illness, medication, circadian disruption, or a separate sleep disorder. Their contribution to diagnosis depends on the broader episode history. NIMH.
5. Psychomotor agitation or retardation
An observable slowing may be evident in delayed answers, quiet and reduced speech, diminished facial animation, or unusually slow movement. Agitation may appear in repeated pacing, constant shifting, or difficulty settling. These are clinically distinct from simply feeling tense, unmotivated, or mentally slow. A clinician considers whether medication effects, substance withdrawal, neurological findings, or other serious conditions account for the behavior. Severe movement changes can affect hydration, nutrition, communication, and the safety of independent living, making their assessment relevant to the intensity of care. NICE.
Psychomotor agitation is observable physical restlessness, while psychomotor retardation refers to visible slowing of movement, speech, or responses. For this formal symptom, the change must be noticeable to others rather than simply felt internally. Pronounced changes can require specialist assessment. NICE.
6. Fatigue or loss of energy
Fatigue can be both disabling and diagnostically nonspecific. The assessment compares energy across workdays and rest days, examines recovery after sleep, and asks whether exhaustion appeared alongside anhedonia or depressed mood. The experience can coexist with chronic pain, anemia, endocrine illness, and sleep-related conditions, all of which may need their own evaluation. Care planning can address the depressive syndrome and another contributor at the same time. The patient’s report of effort matters even when an observer sees completed tasks: external accomplishment can conceal an unusually heavy personal burden. NIMH.
Ordinary tasks can demand disproportionate effort. A person may struggle to initiate work, prepare meals, wash, study, or take part in social activities. Clinicians distinguish this change from fatigue due to physical disease, sleep difficulties, medications, or environmental demands. NIMH.
7. Worthlessness or excessive or inappropriate guilt
A clinician explores the strength, persistence, and context of self-critical beliefs. Proportional remorse for a specific mistake differs from the conviction that one has ruined the lives of others or is personally responsible for events outside one's control. Severe hopelessness and perceived burdensomeness may coexist with suicidal thoughts and warrant further safety questions. When beliefs are fixed despite clear contradictory evidence or accompanied by hallucinations, the evaluation expands to psychotic depression and other possible causes. Treatment planning should be guided by the full clinical state. NICE.
Depressive thinking can involve pervasive self-devaluation, exaggerated responsibility, or feelings of failure that exceed the circumstances. This criterion concerns excessive or inappropriate guilt rather than understandable regret. In severe illness, beliefs can become delusional, requiring prompt professional assessment. NICE.
8. Reduced concentration or indecisiveness
Problems with concentration can affect understanding instructions, sustaining conversations, remembering appointments, and deciding how to organize a routine. They may arise from sleep disruption or anxiety as well as depression, so the clinician asks when the changes began and whether similar difficulties existed before the episode. Attention disorders and cognitive or neurological conditions may coexist with MDD. Repeated measurement of cognition alone does not identify the primary cause. Functional examples—such as needing much longer to complete familiar assignments—often provide an accessible starting point for clinical discussion. NIMH.
Reading, listening, working, remembering, and choosing among ordinary alternatives may become difficult. Patients sometimes describe brain fog. The clinician considers changes from prior functioning, coexisting anxiety, sleep deprivation, developmental conditions, medical illness, and medication effects. NIMH.
9. Recurrent thoughts of death or suicide
Thoughts of death cover experiences with different meanings and degrees of immediate risk. A person may repeatedly wish not to wake up, experience intrusive suicidal ideas, have considered acting on them, or have already engaged in suicidal behavior. Each situation warrants sensitive assessment of timing, intent, protective supports, and current danger. A standard symptom checklist does not replace a collaborative clinical safety process. Clinicians should respond to expressed risk directly even when depression has not been diagnosed. People in imminent danger need emergency services, while crisis support and professional contact can be appropriate in other situations. NICE.
The ninth group involves recurrent thoughts of death, suicidal thoughts, or suicidal behavior. It is never a required symptom for MDD; a person can have MDD without suicidality. Any suicidal expression deserves assessment independently of whether a five-symptom threshold is met. Clinicians ask directly about safety, intent, urgency, past behavior, and appropriate support. NICE.
In the United States, call or text 988 or visit 988 Suicide & Crisis Lifeline for crisis support. Immediate danger requires emergency services. In other countries, use the relevant local crisis and emergency service.
III. Why Five Symptoms Alone Are Insufficient
Consider two hypothetical patients who both report five symptoms. One has experienced profound anhedonia, disturbed sleep, low energy, intense guilt, and concentration decline for several weeks, with major impairment. Another endorses several similar words on a questionnaire following an acute medical illness, without a sustained depressive core symptom or the requisite timing. Their symptom totals look similar while the diagnostic questions differ. This is why the clinician explores the source, duration, severity, co-occurrence, and consequences of each symptom, and why mental-health screening instruments are unsuitable as individual diagnostic verdicts. NICE.
1. A two-week period and change from baseline
The relevant symptoms must cluster during the same two-week period and represent a change from earlier functioning. A person who has experienced chronic insomnia for many years and develops new sadness for several days does not automatically meet MDD episode criteria. Chronology, frequency, and the relation among symptoms are important. Assessment is appropriate before two weeks when deterioration or safety risk is serious. NIMH.
2. Nearly every day and most of the day
Diagnostic frequency is generally sustained rather than episodic fluctuations across isolated moments. Clinicians explore whether symptoms are pervasive, how they vary over the day, and whether they are sufficiently persistent to form the syndrome. Individual symptom definitions have specific nuances, particularly the group involving recurrent death thoughts.
3. Distress and impairment
Clinical significance considers functioning in work, study, relationships, family life, self-care, and ordinary activities, as well as the suffering involved. A person may remain outwardly productive while doing so at substantial psychological cost. Conversely, an isolated difficulty with concentration can have many causes. NICE recommends a comprehensive assessment beyond symptom count. NICE recommendations 1.2.6–1.2.7.
4. Exclusion of alternative causes
Substance or medication effects, physical conditions, and other mental disorders may explain all or part of the syndrome. For MDD, lifetime history of spontaneous mania or hypomania is particularly consequential. Symptoms of psychosis and their relationship to mood episodes must also be investigated. VA/DoD.
5. Subthreshold depression
Clinically important symptoms may exist below the full episode threshold. They can warrant assessment, monitoring, and appropriate intervention. A person should not postpone seeking help while trying to accumulate a particular number of symptoms. Diagnosis is a structured medical process, while need for care is determined by the actual difficulties and risk.
IV. How Clinicians Diagnose MDD
1. Clinical history and timeline
Assessment usually includes onset, duration, prior episodes, fluctuations, prior treatments, work and family functioning, life events, psychiatric history, family history, medication exposure, alcohol and substance use, and relevant physical illnesses. Clinicians ask directly about depressed mood and loss of interest and explore the other symptoms in context. They examine both the patient's report and changes other people may observe. NICE.
2. Symptom screening and follow-up
Screening tools have demonstrable strengths and limitations. An individual participant data meta-analysis published in The BMJ found that a PHQ-9 score threshold of at least 10 had approximately 85% sensitivity and 85% specificity against semistructured diagnostic interviews in pooled study data. These figures describe group-level accuracy and cannot tell an individual whether they have MDD. False-positive and false-negative results are expected in real populations. Screening should therefore lead to a comprehensive assessment that considers other psychiatric and medical conditions, life context, and safety. The USPSTF explicitly requires follow-up after a positive screen.
Questionnaires such as the PHQ-9 can identify people who may need evaluation and help monitor symptoms over time. They cannot confirm MDD on their own. A high score can arise in several conditions, while underreporting may obscure clinically important problems. The USPSTF recommends depression screening for adults with systems for diagnostic assessment and evidence-based treatment. USPSTF.
3. Medical assessment
There is no routine single blood test, genetic result, or brain scan that diagnoses MDD. Clinicians may investigate thyroid dysfunction, chronic disease, medication adverse effects, sleep conditions, neurological problems, or other suspected contributors according to clinical indications. Medical conditions can contribute to or coexist with depression. NIMH.
4. Mental-state and safety assessment
The interview evaluates mood, thought content, cognition, psychomotor changes, possible hallucinations and delusions, the ability to meet essential needs, and suicide risk. When symptoms are severe or acute safety problems exist, specialist or emergency assessment may be appropriate. Clinical safety assessment is broader than a single questionnaire item. NICE.
5. Communication and development
An individual's language, culture, age, and communication needs influence how depressive experiences are expressed. Some people emphasize pain or fatigue; others emphasize numbness, guilt, or loss of pleasure. Clinicians should adapt their approach and, where appropriate and with consent, obtain supplementary observations from trusted people. NICE.
V. Differential Diagnosis
1. Bipolar disorders
Some people initially seek help only during low periods and never volunteer earlier phases of unusually increased energy. A practical lifetime history may examine periods in which friends noticed much faster speech, unusually ambitious activity, limited sleep without resulting fatigue, extravagant decisions, or abrupt changes in behavior. Families may help clarify a pattern when the patient agrees. These observations need interpretation against the full criteria for hypomania or mania and against substance and medication effects. A history consistent with bipolar disorder changes the diagnostic owner and may alter medication safety; the distinction deserves careful specialist assessment rather than a brief checklist. NICE.
An episode that satisfies depressive criteria may belong to bipolar I or II disorder. A lifetime assessment therefore asks about periods of unusually elevated or irritable mood together with increased activity and energy, decreased need for sleep, racing ideas, faster speech, inflated self-confidence, and impulsivity. Hypomania can be overlooked when a person remembers it as a period of exceptional productivity. Antidepressant decisions may change significantly when bipolarity is suspected. NICE.
2. Persistent depressive disorder
Persistent depressive disorder (dysthymia) emphasizes a longer-standing course of depressive symptoms with separate duration rules. A major depressive episode can occur during a longstanding depressed mood. Both symptom intensity and the longitudinal course inform diagnosis. American Psychiatric Association.
3. Grief and bereavement
Grief after the death of someone close may be organized around reminders of the person and changing waves of yearning or sorrow; MDD can involve a more pervasive low mood, anhedonia, or generalized worthlessness. Real experiences frequently overlap, and bereaved people may simultaneously meet depressive criteria. The timing of a death therefore informs a clinical formulation without deciding it. Differentiation requires attention to the course of grief, possible major depressive symptoms, coexisting conditions, functional impact, and safety. The specialist question of prolonged grief disorder should be addressed within its own diagnostic framework rather than treating all post-loss sadness as MDD.
After a bereavement, a person may have profound sadness, loss of appetite, disturbed sleep, and social withdrawal. Contemporary DSM classification does not impose an automatic exclusion of MDD solely because a loss occurred. Evaluation considers the phenomenology and course of grief, depressive syndrome, impairment, and risk. Grief and depression can coexist; prolonged grief has its own diagnostic framework.
4. Adjustment disorder and stress-related responses
Adjustment disorder with depressed mood involves a response to an identifiable stressor evaluated under its own criteria. Experiencing a stressor neither automatically establishes adjustment disorder nor rules out MDD. Clinicians distinguish the syndromes by symptom threshold, timing, and context.
5. Anxiety disorders
MDD commonly coexists with anxiety disorders, whose worry, panic, fear, and sleep problems can overlap with depressive symptoms. Independent evaluation of both conditions can clarify treatment. See Anxiety and Depression: Why They Commonly Co-Occur and GAD vs Depression: Worry, Mood, Energy, and Comorbidity.
6. Medical, substance, and medication-related syndromes
An accurate chronology can be especially informative. Did low mood precede the medical condition, follow the introduction or discontinuation of a medicine, or begin during heavy alcohol use? Are cognitive or physical symptoms better accounted for by sleep disturbance, neurological disease, or a physiological change? The clinician may conclude that multiple contributors coexist. Diagnostic exclusions are meant to improve causal and clinical interpretation, not to invalidate the patient's symptoms. Individuals should discuss suspected adverse drug effects with the relevant prescriber, especially when abrupt discontinuation could create additional risk. NIMH.
Endocrine illness, sleep disorders, pain, neurological conditions, certain medicines, and substance use or withdrawal can produce depression-like symptoms. The clinician reviews the chronology and considers whether the effects explain the syndrome, contribute to an independent depressive episode, or coexist with it. A possible medication effect should be discussed with the prescriber rather than handled by abrupt unsupervised discontinuation. NIMH.
7. Disorders involving psychotic symptoms
Depression with delusions or hallucinations requires evaluation of whether psychotic symptoms occur only during mood episodes or also outside them. MDD with psychotic features, bipolar disorder, schizophrenia-spectrum disorders, and medical causes can require different management. New or severe psychotic symptoms warrant prompt specialist attention. NICE.
VI. Course, Severity, and Remission
A record of episodes describes how the condition unfolds rather than a permanent description of the person. Clinicians review the timing of earlier episodes, intervening wellness, incomplete recovery, and associated treatments. Functional recovery may lag behind a reduction in mood symptoms; residual insomnia, low motivation, or impaired concentration may still affect daily life. Follow-up is particularly important when a patient has experienced recurrent episodes or has risk factors for deterioration. A diagnosis that changes from a current episode to remission reflects a real change in clinical state, and ongoing assessment helps determine the appropriate level of care. VA/DoD.
A diagnosis may be designated as a single episode or recurrent MDD. Clinicians consider earlier periods of illness and recovery when determining the longitudinal course. Severity can be mild, moderate, or severe according to clinical characteristics and impact, not by counting symptoms in isolation. VA/DoD.
Partial remission describes improvement with residual symptoms or an incomplete return from the full episode; full remission concerns resolution of the full syndrome. Relapse and recurrence are clinical course terms referring to the return of symptoms during recovery and later new episodes, although operational boundaries differ across studies. Monitoring mood, functioning, risks, and treatment response helps identify important changes. VA/DoD.
Treatment-resistant depression is a further-line treatment concept commonly considered when at least two appropriate and adequately delivered antidepressant trials have been insufficient, although precise definitions differ. Before using the label, clinicians should re-evaluate bipolar history, comorbidities, adherence, dose and duration adequacy, and alternative causes. NIMH.
VII. Clinical Specifiers and Presentation Patterns
Specifiers refine clinical communication within an established disorder diagnosis. Some describe the current symptom profile, such as anxious distress, melancholic or atypical features, or psychotic features; others describe timing or longitudinal course, such as seasonal pattern. The details can affect risk assessment, specialist referral, treatment choice, or discussion of prognosis, but their assignment requires the specified combination and duration of findings. Medical records should distinguish a formally documented specifier from a patient's informal description. Diagnostic coding conventions can also vary between DSM and international classification systems, which makes the complete clinical formulation more useful than an isolated label.
1. Anxious distress and mixed features
Anxious distress describes clinically important anxiety accompanying a depressive episode. Mixed features indicate specified symptoms characteristic of mania or hypomania during the depressive presentation. Mixed features make bipolar-history assessment especially important. Neither specifier creates a separate stand-alone depressive disease.
2. Melancholic features
Melancholic features describe a characteristic syndrome with marked loss of pleasure or mood nonreactivity and selected additional findings, such as early-morning waking, psychomotor changes, and excessive guilt. Full diagnostic criteria are needed; severity or sadness alone is insufficient to assign the specifier.
3. Atypical features
Atypical features are a technical pattern involving mood reactivity and qualifying additional findings such as increased appetite, hypersomnia, leaden paralysis, or heightened interpersonal rejection sensitivity. Atypical does not mean rare or medically insignificant. It is a clinical specifier, not a separate disorder.
4. Seasonal pattern
Seasonal affective disorder is a popular label for a recurrent seasonal course of depression. DSM-5-TR typically expresses this as a seasonal-pattern specifier for a mood disorder. The pattern requires longitudinal evidence beyond feeling low in one winter, and seasonal depressive episodes can also occur in bipolar disorders. American Psychiatric Association.
5. Psychotic features
MDD with psychotic features involves delusions or hallucinations occurring in the context of depression. Specialist assessment and coordinated care are recommended. NICE discusses antidepressant and antipsychotic combination treatment for appropriately selected patients and ongoing monitoring of psychotic symptoms. NICE section 1.12.
6. Catatonia and peripartum onset
Catatonic features involve marked abnormalities of movement, posture, speech, or behavior and require prompt specialist assessment. Peripartum onset describes a defined temporal relationship between a mood episode and pregnancy or childbirth. Comprehensive perinatal and postpartum assessment belongs to its specialist clinical domain.
VIII. Common Informal Labels
High-functioning depression and smiling depression are public descriptions rather than DSM-5-TR diagnoses or official specifiers. They may describe people who continue outward responsibilities or conceal suffering, but do not indicate a unique symptom threshold, severity category, or treatment regimen. A person using these terms may meet criteria for MDD, persistent depressive disorder, another condition, or no current disorder. Assessment determines the clinical picture. APA DSM overview.
Depression without sadness describes presentations dominated by anhedonia, emotional numbness, or fatigue. The core diagnostic requirement already permits loss of pleasure without prominent sadness. Historical terminology such as depressive neurosis has its own conceptual history; see Depressive Neurosis: Historical Meaning, Dysthymia, and Modern Depressive Disorders.
IX. Developmental and Medical Contexts
Across the lifespan, the same diagnostic framework requires age-sensitive interviewing. A teenager who becomes irritable, withdraws from previously enjoyed activities, or experiences academic deterioration may require evaluation even without the adult vocabulary for hopelessness. In older adults, medical comorbidity, medication exposure, sleep disruption, and changes in cognition can complicate interpretation. Clinical assessment should remain attentive to potential co-occurring disorders, developmental context, and the person's usual pattern of functioning. Positive screening results are followed by appropriate clinical evaluation rather than directly translated into a diagnosis. American Academy of Pediatrics; USPSTF.
Depression in children and adolescents can involve irritability, academic decline, loss of interest, sleep and appetite changes, withdrawal, and distress. Clinical evaluation should consider development, family and school circumstances, confidentiality, and safety. Screening results require diagnostic follow-up, and treatment planning must account for age-specific psychotherapy and medication considerations. American Academy of Pediatrics.
In older adults, depression can overlap with chronic illness, medication effects, cognitive changes, pain, loss, and changes in social support. Clinicians evaluate alternative causes and personalize treatment to physical health and potential adverse effects. USPSTF.
Adverse life experiences, social stress, family history, and chronic health conditions may contribute to risk without constituting diagnostic proof or deterministic explanations for an individual. For one separately owned developmental question, see Childhood Trauma and Depression: Risk, Mechanisms, and Treatment. NIMH.
X. Evidence-Based Treatment Orientation
Treatment evidence should be interpreted by intervention class and clinical population. A large network meta-analysis of 21 antidepressants found that evaluated antidepressants were more efficacious than placebo for acute treatment of adult MDD, with differences in efficacy and acceptability among treatments. A Cochrane systematic review of behavioral activation found evidence for possible benefit while emphasizing limitations in certainty and longer-term data. These findings establish the relevance of evidence-based treatment choices without implying that one treatment is optimal for every patient. Shared decision-making integrates previous responses, risks, access, symptoms, medical circumstances, and the individual's goals.
After a diagnosis, clinicians discuss the degree of severity, prior episodes, safety, patient preferences, access, current medicines, and coexisting medical or psychiatric diagnoses. Depression-specific cognitive behavioral therapy, behavioral activation, interpersonal psychotherapy, antidepressants, and selected combinations have evidence-based roles. The choice depends on the presentation rather than diagnosis alone. NICE; VA/DoD.
Antidepressants may take several weeks to produce substantial benefits. Side effects, drug interactions, bipolar history, and increased suicidal thinking or behavior in some younger people during treatment changes require informed decisions and follow-up. Abrupt discontinuation can produce withdrawal symptoms; treatment changes should be discussed with the prescriber. NIMH; NICE.
Specialist treatments for selected cases include electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and ketamine- or esketamine-related interventions under their respective clinical indications and monitoring arrangements. They have different benefits, risks, regulatory requirements, and evidence bases. ECT can be considered in severe or urgent clinical presentations; ketamine-based treatments are not home self-treatment. VA/DoD; NICE.
Continuation treatment, relapse prevention, functional recovery, and review of residual symptoms are important aspects of care. When improvement is inadequate, clinicians reassess the diagnosis and treatment plan before escalating interventions. NICE.
XI. Practical Steps for Seeking an Evaluation
A useful consultation note can contain a short timeline: the first noticeable change, which symptoms followed, their frequency over two or more weeks, and examples of how daily functioning has changed. Include prescribed and nonprescribed substances, relevant illnesses, family history when known, and earlier periods of increased energy or reduced sleep. If the person has taken a questionnaire, bring the results as supplementary information. Describe distress in plain language; a patient does not need perfect diagnostic vocabulary to receive an appropriate assessment. When an immediate safety issue exists, urgent help takes priority over completing notes or questionnaires.
Arrange a consultation if depressive symptoms persist, worsen, or disrupt daily living. It helps to record when changes began, how often symptoms occur, what activities have become difficult, changes in sleep and appetite, current medicines and medical conditions, and any past similar periods. Mention any episodes of unusually increased energy, reduced need for sleep, impulsivity, or elevated mood because these may alter diagnostic interpretation.
Seek urgent assessment for thoughts of suicide with current intent, new psychotic symptoms, severe deterioration, or inability to meet basic needs. Safety support is appropriate even before a full depressive syndrome has been diagnosed. Family members can offer practical help accessing care while respecting privacy and autonomy. NIMH.
XII. Frequently Asked Questions
1. How many symptoms are required?
At least five of nine defined groups in the same two-week period, including low mood or reduced interest or pleasure, with important duration, impairment, and exclusion conditions. NICE.
2. Can MDD exist without sadness?
Yes. Marked loss of interest or pleasure can supply the required core symptom, together with other qualifying clinical findings. NIMH.
3. Does a PHQ-9 score confirm MDD?
No. A questionnaire result can support screening and tracking but requires professional diagnostic follow-up. USPSTF.
4. Is MDD the same as a major depressive episode?
An episode is a specified symptom syndrome; MDD is the disorder-level formulation after lifetime-history and exclusion assessment. Depressive episodes also occur in bipolar disorders.
5. Can someone with MDD maintain employment?
Yes. The degree of subjective suffering and functional change matters, even when outward routines continue. Functioning is assessed relative to the person's usual baseline.
6. Is seasonal affective disorder a formal separate diagnosis?
Seasonal depression is commonly described through a seasonal-pattern specifier and may occur in unipolar or bipolar mood disorders. American Psychiatric Association.
7. Is smiling depression an official diagnosis?
No. Smiling depression is an informal description, not a DSM-5-TR disorder or diagnostic subtype.
8. Does grief exclude major depressive disorder?
No. Bereavement alone does not automatically rule out MDD; clinicians distinguish grief and depression using the full presentation and history.
9. Are antidepressants always necessary?
No. Psychotherapy, medication, or a combination may be appropriate depending on severity, previous response, preferences, and risks. NICE.
10. Can a first episode recur?
Some people experience one episode; others have recurrent depression. Follow-up and ongoing care help identify residual symptoms and reduce recurrence risk where possible. VA/DoD.
XIII. Conclusion
Major depressive disorder is recognized through an integrated assessment of the depressive episode syndrome, a minimum duration, its effects on life, and diagnostic exclusions. Precise diagnosis requires evaluation of past mania or hypomania, medical and medication effects, psychosis, comorbidities, and safety. Clinical care then follows the person's specific needs, risks, preferences, and course.
Related Articles
References
• American Academy of Pediatrics. (2018). Guidelines for Adolescent Depression in Primary Care: Part I. Pediatrics, 141(3), e20174081. https://doi.org/10.1542/peds.2017-4081
• American Psychiatric Association. (2022). DSM-5-TR: Classification information. https://www.psychiatry.org/patients-families/what-is-the-dsm
• American Psychiatric Association. What Is Depression? https://www.psychiatry.org/patients-families/depression/what-is-depression
• Cipriani, A., et al. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. The Lancet, 391, 1357–1366. https://doi.org/10.1016/S0140-6736(17)32802-7
• National Institute for Health and Care Excellence. (2022; reviewed January 2026). Depression in Adults: Treatment and Management. NG222. https://www.nice.org.uk/guidance/ng222/chapter/Recommendations
• National Institute of Mental Health. Depression. https://www.nimh.nih.gov/health/publications/depression
• Negeri, Z. F., et al. (2021). Accuracy of the Patient Health Questionnaire-9 for screening to detect major depression: Updated systematic review and individual participant data meta-analysis. BMJ, 375, n2183. https://doi.org/10.1136/bmj.n2183
• Uphoff, E., et al. (2020). Behavioural activation therapy for depression in adults. Cochrane Database of Systematic Reviews, CD013305. https://doi.org/10.1002/14651858.CD013305.pub2
• US Department of Veterans Affairs and Department of Defense. (2022). Management of Major Depressive Disorder Clinical Practice Guideline. https://www.healthquality.va.gov/guidelines/MH/mdd/
• US Preventive Services Task Force. (2023). Depression and Suicide Risk in Adults: Screening. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults